Towards the lean lab: the industry challenge.
暂无分享,去创建一个
[1] P. Hogendoorn,et al. Molecular pathology of sarcomas: concepts and clinical implications , 2009, Virchows Archiv.
[2] K. Owzar,et al. Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] P. Wesseling,et al. Molecular Diagnostics as a Tool to Personalize Treatment in Adult Glioma Patients , 2006, Technology in cancer research & treatment.
[4] C. Fletcher,et al. Molecular prognostication for soft tissue sarcomas: are we ready yet? , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] S. Bonin,et al. Effects of Formalin, Methacarn, and FineFIX Fixatives on RNA Preservation , 2010, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[6] Mariano Provencio,et al. Screening for epidermal growth factor receptor mutations in lung cancer. , 2009, The New England journal of medicine.
[7] Michael Krauthammer,et al. PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells , 2010, Pigment cell & melanoma research.
[8] P. Kaposi-Novák,et al. Effect of Formalin, Acetone, and RNAlater Fixatives on Tissue Preservation and Different Size Amplicons by Real-Time PCR from Paraffin-Embedded Tissue , 2004, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[9] M. Monden,et al. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. , 1999, Nucleic acids research.
[10] G. Hortobagyi,et al. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Klebs. Die Einschmelzungs-Methode, ein Beitrag zur mikroskopischen Technik , 1869 .
[12] W. Böcker. [WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics]. , 2002, Verhandlungen der Deutschen Gesellschaft fur Pathologie.
[13] Claudio Montero,et al. The Antigen-Antibody Reaction in Immunohistochemistry , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[14] D. Dabbs. Immunohistochemical protocols: back to the future. , 2008, American journal of clinical pathology.
[15] M. Hayat. Microscopy, Immunohistochemistry, and Antigen Retrieval Methods: For Light and Electron Microscopy , 2002 .
[16] M. Meyerson,et al. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. , 2005, The New England journal of medicine.
[17] T. Ruers,et al. Cost effectiveness of a new strategy to identify HNPCC patients , 2004, Gut.
[18] Bernd W Scheithauer,et al. Development of the WHO Classification of Tumors of the Central Nervous System: A Historical Perspective , 2009, Brain pathology.
[19] C. Oliver,et al. Fixation and embedding. , 1999, Methods in molecular biology.
[20] N. Goldstein,et al. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. , 2003, American journal of clinical pathology.
[21] K. Flaherty,et al. Genetic subgrouping of melanoma reveals new opportunities for targeted therapy. , 2009, Cancer research.
[22] A. Leong,et al. The Effects of Progressive Formaldehyde Fixation on the Preservation of Tissue Antigens , 1989, Pathology.
[23] C. Fletcher. The evolving classification of soft tissue tumours – an update based on the new 2013 WHO classification , 2014, Histopathology.
[24] J. M. Wilkinson,et al. Evaluation of Ethanol-based Fixatives as a Substitute for Formalin in Diagnostic Clinical Laboratories , 2000 .
[25] A. Sapino,et al. Critical steps in tissue processing in histopathology. , 2012, Recent patents on DNA & gene sequences.
[26] R. Dapson. Fixation for the 1990's: a review of needs and accomplishments. , 1993, Biotechnic & histochemistry : official publication of the Biological Stain Commission.
[27] Sabine Tejpar,et al. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] T. O'Leary,et al. Effects of formaldehyde fixation on protein secondary structure: a calorimetric and infrared spectroscopic investigation. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[29] P. Wesseling,et al. MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas , 2007, Laboratory Investigation.
[30] J. Meyerhardt,et al. KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803 , 2009, Clinical Cancer Research.
[31] V. Nosé,et al. Endocrine Tumors as Part of Inherited Tumor Syndromes , 2011, Advances in anatomic pathology.
[32] H. Rugo,et al. The Role of Trastuzumab in Early Stage Breast Cancer: Current Data and Treatment Recommendations , 2007, Current treatment options in oncology.
[33] P. Wesseling,et al. Preparing pathology for personalized medicine: possibilities for improvement of the pre‐analytical phase , 2011, Histopathology.
[34] Richard D Kolodner,et al. Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. , 2009, Cancer research.
[35] A. Iafrate,et al. Molecular Diagnostic Testing in Malignant Gliomas: A Practical Update on Predictive Markers , 2008, Journal of neuropathology and experimental neurology.
[36] William E. Grizzle,et al. Introduction to the Theory and Practice of Fixation of Tissues , 2001 .
[37] C. Antonescu,et al. Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation , 2005, Clinical Cancer Research.
[38] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.
[39] Gianni Bussolati,et al. Tissue transfer to pathology labs: under vacuum is the safe alternative to formalin , 2008, Virchows Archiv.
[40] M. Key,et al. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[41] J. Lasota,et al. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours , 2008, Histopathology.
[42] A. Sapino,et al. Formalin Fixation at Low Temperature Better Preserves Nucleic Acid Integrity , 2011, PloS one.
[43] M. Ligtenberg,et al. Interpretation of Immunohistochemistry for Mismatch Repair Proteins is Only Reliable in a Specialized Setting , 2008, The American journal of surgical pathology.